Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alignment Healthcare (ALHC) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to 1.58%.

  • Alignment Healthcare's EBITDA Margin rose 33800.0% to 1.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86%, marking a year-over-year increase of 49700.0%. This contributed to the annual value of 2.78% for FY2024, which is 30500.0% up from last year.
  • As of Q3 2025, Alignment Healthcare's EBITDA Margin stood at 1.58%, which was up 33800.0% from 2.93% recorded in Q2 2025.
  • In the past 5 years, Alignment Healthcare's EBITDA Margin registered a high of 2.93% during Q2 2025, and its lowest value of 18.33% during Q1 2021.
  • In the last 5 years, Alignment Healthcare's EBITDA Margin had a median value of 6.29% in 2023 and averaged 6.23%.
  • In the last 5 years, Alignment Healthcare's EBITDA Margin crashed by -204100bps in 2021 and then soared by 111700bps in 2022.
  • Over the past 5 years, Alignment Healthcare's EBITDA Margin (Quarter) stood at 13.21% in 2021, then increased by 1bps to 13.12% in 2022, then skyrocketed by 41bps to 7.75% in 2023, then soared by 71bps to 2.24% in 2024, then surged by 170bps to 1.58% in 2025.
  • Its EBITDA Margin was 1.58% in Q3 2025, compared to 2.93% in Q2 2025 and 0.17% in Q1 2025.